| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/21/2002 | CA2419081A1 Micronized torsemide |
| 02/21/2002 | CA2419073A1 Novel alicyclic imidazoles as h3 agents |
| 02/21/2002 | CA2419033A1 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors |
| 02/21/2002 | CA2419008A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | CA2418853A1 2,4-substituted pyridine derivatives |
| 02/21/2002 | CA2418531A1 Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/21/2002 | CA2387002A1 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/20/2002 | EP1180519A1 Hydrochloride of fused-heterocycle compound |
| 02/20/2002 | EP1180518A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 02/20/2002 | EP1180514A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 02/20/2002 | EP1180151A2 Protein kinases |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180140A1 Variants of traf2 which act as an inhibitor of tnf-alpha signaling pathway |
| 02/20/2002 | EP1180122A1 Structural models for cytoplasmic domains of transmembrane receptors |
| 02/20/2002 | EP1180105A2 Substituted aza-oxindole derivatives |
| 02/20/2002 | EP1180103A1 Renin inhibitors |
| 02/20/2002 | EP1180102A1 Mutual prodrugs of amlodipine and atorvastatin |
| 02/20/2002 | EP1180101A1 Compounds having cytokine inhibitory activity |
| 02/20/2002 | EP1180100A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/20/2002 | EP1180098A1 New compounds |
| 02/20/2002 | EP1180097A1 Mutual salt of amlodipine and atorvastatin |
| 02/20/2002 | EP1180040A2 Methods for treating congestive heart failure |
| 02/20/2002 | EP1180029A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method |
| 02/20/2002 | EP1180028A1 Il-8 receptor antagonists |
| 02/20/2002 | EP1180027A1 Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
| 02/20/2002 | EP1180026A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 02/20/2002 | EP1180025A1 Il-8 receptor antagonists |
| 02/20/2002 | EP1180015A1 Generation of therapeutic microfoam |
| 02/20/2002 | EP0841922B1 1h-4(5)-substituted imidazole derivatives |
| 02/20/2002 | CN1336926A Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 02/20/2002 | CN1336924A Amide and urea derivatives as 5-HT reuptake inhibitors and at 5-HT 1B/1D ligands |
| 02/20/2002 | CN1336922A Hypolipidemic and antioxidant morpholine derivatives |
| 02/20/2002 | CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/20/2002 | CN1336920A Telmisartan polymorphs, methods for producing same and their use in prepn. of a medicament |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336821A Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their prepn. and therapeutic use |
| 02/20/2002 | CN1336552A Method for detecting failure welding of IC terminal by using resonating type sensor coil |
| 02/20/2002 | CN1336382A Endothelial cell growth resisting engineered protein |
| 02/20/2002 | CN1336380A Anticancer polypeptide |
| 02/20/2002 | CN1336369A Benzopyran compound, and its pharmaceutical use |
| 02/20/2002 | CN1336227A Traditional Chinese medicine for treating rheumatic heart disease |
| 02/20/2002 | CN1336225A Cerebral thrombus treating traditional Chinese medicine |
| 02/20/2002 | CN1336222A Cerebral hemorrhage treating traditional Chinese medicine |
| 02/20/2002 | CN1336221A Angiocardiopathy treating traditional Chinese medicine |
| 02/20/2002 | CN1336206A Health tea for preventing and treating hypertension, byperlipemia and high blood viscosity disease |
| 02/20/2002 | CN1336183A Chinese medicine for fuming and washing piles |
| 02/20/2002 | CN1079431C Method for extracting SOD from earthworm, and SOD series health-care food |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/20/2002 | CN1079260C Oral liquid for treating piles |
| 02/20/2002 | CN1079246C Active gastrodia elata and its prepn. |
| 02/20/2002 | CN1079243C Medicine for treating cardiovascular disease and its prepn. technology |
| 02/20/2002 | CN1079233C Medicinal compositions for curing cardio-vascular diseases and benign prostatomegaly |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | US6348602 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/19/2002 | US6348497 Prosthetic joints by reducing bone degradation |
| 02/19/2002 | US6348487 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/19/2002 | US6348476 Ion exchange inhibitor for cardiovascular disorders |
| 02/19/2002 | US6348472 NPY antagonists: spiroisoquinolinone derivatives |
| 02/19/2002 | US6348466 CRF receptor antagonists and methods relating thereto |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348213 Intravenously administering liposomes having lipid component comprising phosphatidylcholine having same acyl chains as phosphatidylcholines in heart cells of younger subjects, repeating until drop in serum creatine phosphokinase is noted |
| 02/19/2002 | CA2203274C Apolipoprotein-b synthesis inhibitors |
| 02/19/2002 | CA2126135C Use of human protein c for prevention and treatment of depositions of thrombocytes |
| 02/19/2002 | CA2087274C 4-alkylimidazole derivatives |
| 02/18/2002 | CA2355411A1 Combination therapy using sympathetic nervous system antagonists and endothelin antagonists |
| 02/14/2002 | WO2002012539A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012471A2 Angiotensin converting enzyme homolog and uses therefor |
| 02/14/2002 | WO2002012470A2 A member of the lysyl oxidase gene family |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012448A1 Methods for culturing human lung mast cells and uses thereof |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | WO2002012307A1 Urocortin proteins and uses thereof |
| 02/14/2002 | WO2002012258A1 New immunoeffector compounds |
| 02/14/2002 | WO2002012250A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 02/14/2002 | WO2002012246A1 Pyrrolotriazolopyrimidinone derivatives |
| 02/14/2002 | WO2002012242A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012238A2 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012233A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | WO2002012228A1 Cinnoline compounds |
| 02/14/2002 | WO2002012227A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012226A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012207A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | WO2002011779A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter |
| 02/14/2002 | WO2002011769A1 Vascular endothelial growth factor 2 |
| 02/14/2002 | WO2002011766A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |